News

FDA recently stopped importation and sent warning letters to numerous online sellers of illegal opioids, oncology drugs and other medicines.

Pharmacy benefit managers, cardiologists, and others praised a pharma maker for significantly reducing the price of its high cholesterol drug.

Early results from a first-of-its-kind study suggests that typical use of a fertility app is effective for avoiding an unplanned pregnancy. Payment mechanisms will need to be considered by payers.

Good leaders don’t just rely on one managerial style-they get the best out of every team member by meeting their needs.

A survey from Vizient identifies top strategies for the treatment of pain.

Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.

It can be challenging for patients with schizophrenia to keep to a medication regimen-here are the reasons why it’s important to invest in strategies to help them stay compliant.

Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.

A novel treatment for patients with moderate-to-severe asthma is now on the market.

A survey from insuranceQuotes.com has surprising findings about open enrollment and the ACA.

Home non-invasive ventilation supports longer lives, fewer readmissions, and lower costs than other devices, based on findings of a KPMG study.

Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.

Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.

A Wamberg Genomic Advisors’ Cancer Survey has revealing findings from people dealing directly with cancer.

As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.

With healthcare being a key issue in the midterm elections, here are 11 things healthcare executives should keep in mind.

A new study was conducted to better understand the landscape of coverage of non-pharmacologic treatments for chronic pain among public and private insurers in the United States. Here’s what it found.

UPMC Health Plan has recently entered into two value-based contracts for medications related to treating diabetes and opioid addiction.

The launch of a new connected health platform will aid in management of diseases such as diabetes.

FDA approved a new antibiotic to treat community-acquired bacterial pneumonia (CABP) and acute skin and skin structure infections (ABSSSI).

A new study linking attention-deficit hyperactivity disorder (ADHD) drugs and Parkinson’s disease could cause prescribers to re-think prescribing the medications.

Healthcare experts detail three policies that MCOs should keep a close eye on.

Innovative PBM performance-based pharmacy networks focus on reducing costs and Improving clinical outcomes

These technology solutions on the market can treat chronic pain, allowing patients to eliminate or decrease their dependence on opioid drugs.

Here are the top 3 new approvals from FDA.

Here are five of the most promising healthcare technologies that will make your healthcare organization in step with the future.

In the managed healthcare market, words like logical, predictable, or stable are seldom used anymore. Instead, for healthcare executives, disruption is the norm.